z-logo
open-access-imgOpen Access
A case of complete atrioventricular block associated with primary cardiac lymphoma reversed without cardiac pacemaker implantation
Author(s) -
Bowen Hu,
Jian Zhao,
Xuefang Liang,
Changzhen Ren,
Na Li,
Chun Liang
Publication year - 2022
Publication title -
journal of international medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 57
eISSN - 1473-2300
pISSN - 0300-0605
DOI - 10.1177/03000605221089780
Subject(s) - medicine , pericardiocentesis , atrioventricular block , pericardial effusion , lymphoma , heart block , chemotherapy , biopsy , pericardium , surgery , atrioventricular node , cardiology , electrocardiography , radiology , tachycardia
Primary cardiac lymphoma (PCL) is a rare malignant lymphoma that is characteristically confined to the heart and/or pericardium. Here, the case of a 70-year-old male patient with complete atrioventricular block (AVB) associated with PCL is presented. The patient had a 10-month history of palpitation and electrocardiogram (ECG) showed a complete AVB. Additionally, transthoracic echocardiography indicated pericardial effusion where atypical lymphoid cells were identified by pericardiocentesis. Subsequent mediastinal lymph node biopsy revealed non-germinal centre diffuse large B-cell lymphoma. Therefore, a diagnosis of PCL was confirmed. As the patient’s vital signs were stable, he was prescribed chemotherapy without pacemaker implantation. After chemotherapy, the patient achieved remission and dynamic ECG demonstrated no recurrence of AVB. The present case demonstrates that although PCL initially manifesting as complete AVB is rare, this possibility should not be ignored when a new AVB without definite aetiology is encountered. In addition, if the vital signs of the patient are stable, pacemaker implantation may be postponed until the treatment effect of chemotherapy has been assessed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here